Browse > Article

CLINICOPATHOLOGIC AND IMMUNOHISTOCHEMICAL STUDY IN PLEOMORPHIC ADENOMA  

Kim, Kyung-Wook (Dept. of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University)
Han, Se-Jin (Dept. of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University)
Lee, Sang-Gu (Dept. of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.32, no.4, 2006 , pp. 384-390 More about this Journal
Abstract
Pleomorphic adenoma is the most common salivary benign tumor, constituting over 60% of parotid gland tumor, 25% of sublingual gland tumor and 50% of minor salivary gland tumor. It is somewhat more frequent in the fourth to sixth decades. The recurrent rate which enforces only a simple enucleation is very high $(20{\sim}45%)$. Histologically, it contains the epithelial cell, the myo-epithelial cell and mesenchymal ingredient, which is various aspect. We analyzed clinicopathologically and immunohistochemically the patients(34 cases) who are diagnosed with pleomorphic adenoma in Dept. of Oral & Maxillofacial Surgery, College of Dentisty, Dankook university since 1998. The results are as follow: 1. The incidence of the tumor was most frequent in age 30 to 50. The ratio of male to female was 1:1.43. 2. The most chief complain was a painless mass(94.1%) and the duration time was more than decade in 18 cases(52.9%). 3. Palate(soft & hard palate) was the most occurred site(64.7%). In major salivary glands, the parotid gland was the most frequent site(17.6%). 4. The tumor size was 2 to 3cm on the average. Most of tumors were with capsule(91.2%). 5. Surgical excision was a main treatment method(20 cases, 58.8%) and 14 cases were excised with a glandectomy, 1 case was treated with a partial maxillectomy. Only 1 case of all cases was recurred. 6. Histopathologically, 9 cases(26.5%) were cellular type, 11 cases(32.4%) were intermediate(classic) type and 14 cases(41.1%) were myxoid type. 7. Immunohistochemically, the specimen of all tumors reacted positively to cytokeratin and vimentin marker.
Keywords
Pleomorphic adenoma; Salivary gland; Cytokeratin; Vimentin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 McFarland J: Three hundred mixed tumors of the salivary glands, of which 69 recurred. Surg Gynecol Obstet 1936;63:457-468
2 Ellis GL, Auclair PL, Gnepp DR: Surgical Pathology of the Salivary Glands. Philadelphia, WB Saunders, 1991
3 Stennert E, Lichius OG, Klussmann JP, Arnold G: Histology of pleomorphic adenoma in the parotid gland; a prospective unselected series of 100 cases. Laryngoscope 2001;111:2195-2200   DOI   ScienceOn
4 Mcgurk M, Renehan A, Gleave EN, Hancock BD: Clinical significance of the tumor capsule in the treatment of parotid pleomorphic adenomas. Br J Surg 1996;83:1747-1749   DOI   ScienceOn
5 Waldron CA, El-Mofty SK, Gnepp DR: Tumors of the intraoral minor salivary glands; A demographic and histologic study of 426cases. Oral Surg Oral Med Oral Pathol 1988;66:323-333   DOI   ScienceOn
6 Moll R, Franke WW, Schiller DL: The catalogue of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11   DOI   ScienceOn
7 Peterson LJ, Ellis EIII, Hupp JR, Tucker MR: Contemporary oral and maxillofacial surgery, 2nd ed. p.497-524, St. Louis, C.V. Mosby, 1993
8 Buxton RW, Maxwell JH & French AJ: Surgical treatment of epithelial tumors of the parotid gland. Surg Gynecol Obstet 1953;97:401- 416
9 Renehan A et al.: Analysis of the treatment of 114 patients with recurrent pleomorphic adenoma. Am J Surg 1996;172(6):710-4   DOI   ScienceOn
10 Kusama K, Iwanari S, Aisaki K, Wada M, Ohtani J, Itoi K, Hanai KI, Shimizu K, Komiyama K, Kudo I, Moro I: Intraoral minor salivary gland tumors: a retrospective study of 129 cases. J Nihon Univ Sch Dent 1997;39:128-132   DOI   ScienceOn
11 Archer WH: Oral and maxillofacial surgery, 5th ed. p518-924, Philadelphia, W.B.Saunder, 1975
12 Guim A & Parrott NR: Parotid tumours: a review of parotid tumour surgery in the Northern Regional Health Authority of the United Kingdom 1978-1982. Br J Surg 1988;75:1144-1146   DOI   ScienceOn
13 Batsakis JG, Kraemer B, Sciubba JJ: The pathology of head and neck tumors: the myoepithelial cell and its participation in salivary gland neoplasia: part 17. Head Neck S urg 1983;5:222-33   DOI
14 Seifert G, Miehlke A, Haubrich J, Chilla R: Disease of the Salivary Glands. New York, George Thieme Verlag, 1992
15 Jong-Ryoul Kim, Bong-Wook Park, June-Ho Byun et al.: A clinical study of pleomorphic adenoma in salivary glands. J Kor Oral Maxillofac Surg 2005;31:170-177   과학기술학회마을
16 J. Phillip Sapp et al.: Contemporary Oral and Maxillofacial pathology. Mosby, 1997
17 Angelov A et al.: Immunohistochemical study of pleomorphic adenoma. Bull Group Int Rech Sci Stomatol Odontol 1996;34:67-75
18 Colvin RB et al.: Diagnostic immunopathology. 2nd. ed. Raven press 455. 1995
19 Seifert G, Sobin LH: The World Health Organization's Histological Classification of Salivary Gland Tumors: a commentary on the second edition. Cancer 1992;70:379-85   DOI   ScienceOn
20 Maynard JD: Management of pleomorphic adenoma of the parotid. Br J Surg 1988;75:30:308
21 McFarland J: Histopathologic prognosis of salivary gland mixed tumors. Am J Med Sci 1942;203:502-519   DOI
22 John E. Norman, Mark McGurk: Color atlas and text of the salivary glands disease, disorders and surgery. Mosby-Wolfe. 1995;63-65, 229-240
23 McFarland J: Ninety tumors of the parotid region, in all of which the post operative history was traced. Am J Med Sc 1926;172:804-848   DOI